Table 2.
Gene symbol | Region location (GRCg37) |
---|---|
SMG1P2 | chr16:29 556 332–29 625 038 |
MIR3680-2 | chr16:29 610 500–29 610 586 |
SLC7A5P1 | chr16:29 624 424–29 625 038 |
CA5AP1 | chr16:29 629 996–29 647 652 |
SPN | chr16:29 674 271–29 681 828 |
QPRT | chr16:29 690 329–29 710 020 |
RN7SKP127 | chr16:29 742 372–29 742 725 |
C16orf54 | chr16:29 753 784–29 757 340 |
ZG16 | chr16:29 789 561–29 792 969 |
KIF22 | chr16:29 802 034–29 816 706 |
MAZ | chr16:29 817 417–29 822 504 |
LOC100289283 | chr16:29 821 745–29 823 178 |
PRRT2 | chr16:29 823 409–29 827 202 |
PAGR1 | chr16:29 827 528–29 833 816 |
MVP | chr16:29 831 715–29 859 360 |
CDIPT | chr16:29 869 677–29 874 609 |
CDIPT-AS1 | chr16:29 875 004–29 879 374 |
SEZ6L2 | chr16:29 882 480–29 910 585 |
ASPHD1 | chr16:29 912 147–29 917 377 |
KCTD13 | chr16:29 917 657–29 937 553 |
TMEM219 | chr16:29 973 351–29 984 373 |
TAOK2 | chr16:29 985 188–30 003 582 |
HIRIP3 | chr16:30 003 642–30 007 417 |
INO80E | chr16:30 007 530–30 017 115 |
DOC2A | chr16:30 016 835–30 024 917 |
C16orf92 | chr16:30 034 655–30 036 023 |
FAM57B | chr16:30 035 744–30 042 186 |
ALDOA | chr16:30 064 411–30 081 741 |
PPP4C | chr16:30 087 297–30 096 698 |
TBX6 | chr16:30 097 114–30 103 205 |
YPEL3 | chr16:30 103 635–30 107 537 |
LOC101928595 | chr16:30 107 751–30 116 777 |
LOC100506914 | chr16:30 107 751–30 116 841 |
GDPD3 | chr16:30 116 131–30 124 878 |
MAPK3 | chr16:30 125 426–30 134 630 |
CORO1A | chr16:30 194 731–30 200 397 |
ALDOA, aldolase, fructose-bisphosphate A; ASPHD1, aspartate beta-hydroxylase domain-containing 1; C16orf54, chromosome 16 open reading frame 54; C16orf92, chromosome 16 open reading frame 92; CA5AP1, carbonic anhydrase 5A pseudogene 1; CDIPT, CDP-diacylglycerol-inositol 3-phosphatidyltransferase; CDIPT-AS1, CDIPT antisense RNA 1; CORO1A, coronin 1A; DOC2A, double C2-like domain-containing protein alpha; FAM57B, family with sequence similarity 57 member B; GDPD3, glycerophosphodiester phosphodiesterase domain-containing 3; HIRIP3, HIRA-interacting protein 3; INO80E, INO80 complex subunit E; KCTD13, potassium channel tetramerization domain-containing 13; KIF22, kinesin family member 22; MAPK3, mitogen-activated protein kinase 3; MAZ, MYC-associated zinc finger protein (purine-binding transcription factor); MIR3680-2, microRNA 3680-2; MVP, major vault protein; PAGR1, PAXIP1 associated glutamate rich protein 1; PPP4C, protein phosphatase 4 catalytic subunit; PRRT2, proline-rich transmembrane protein 2; QPRT, quinolinate phosphoribosyltransferase; RN7SKP127, 7SK small nuclear pseudogene 127; SEZ6L2, seizure related 6 homolog like 2; SLC7A5P1, solute carrier family 7 member 5 pseudogene 1; SMG1P2, nonsense mediated mRNA decay associated PI3K related kinase pseudogene 2; SPN, sialophorin; TAOK2, TAO kinase 2; TBX6, T-box transcription factor TBX6; TMEM219, transmembrane protein 219; YPEL3, Yippee-like 3; ZG16, zymogen granule protein 16.